Effects of physical activity and diet on lipoprotein(a)

Medicine and Science in Sports and Exercise

Volumn 29, Issue 11, 1997, Pages 1429-1436

  Mackinnon, Laurel T ^a   Hubinger, Lyle ^a   Lepre, Frank ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoprotein(a); Blood lipids; Cardiovascular disease risk factors; Exercise

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILD; DIETARY INTAKE; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARTERIOSCLEROSIS; CHILD; CROSS-SECTIONAL STUDIES; DIET, FAT-RESTRICTED; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; INTERVENTION STUDIES; LIFE STYLE; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030775724     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199711000-00007     Document Type: Review

References (65)

1. ALBERS. J. J., H. M. TAGGART, D. APPLEBAUM-BOWDFN, S. HAFFNER, C. H. CHESTNUT III and W. R. HAZZARD. Reduction of lecithincholesterol acyltransferase apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. Biochem. Biophys. Acta 795:293-296, 1984.
2. ALBERS, J. J., S. M. MARCOVINA. and M. S. LODGE. The unique lipoprotein(a): properties and immunochemical measurement. Clin. Chem. 36:2019-2026, 1990.
3. ARMSTRONG, V. W., P. CREMER. E. EBERLE, et al The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 62:249-257, 1986.
4. AUSTIN, A., J. JANOSKY. V. WARTY, and S. ARSLANIAN. The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care 16:421-425, 1993.
5. BARTENS, W. and C. WANNKR. Lipoprotein(a): new insights into an atherogenic lipoprotein. Clin. Invest. 72:558-567, 1994.
6. BERG, K. A new serum type system in man-the l.p system. Acta Pathol. Micmbiol. Scand. 59:(Suppl.):369. 1963.
7. BERG, K., G. DAHLEN. and A. L. BORRESON. Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary-heart disease in middle-aged males. Clin. Genet. 16:347-352, 1979.
8. BERG. K., l. FREY, M. W. BAUMSTARK, M. HALLE, and J. KEUL. Physical activity and lipoprotein lipid disorders. Sports Med. 17: 6-21, 1994.
9. BERG. K. Lipoprotein(a): an overview. Chem. Physics Lipids 671 68:9-16, 1994.
10. BROWN. M. S. and J. L. GOLDSTEIN. Plasma lipoproteins: teaching old dogmas new tricks. Nature 330:113-114, 1987.
11. CAMBELL, B., J. TAIE. F. LEPRE. and P. HICKMAN. Lipoprotein(a): biology, clinical utility and measurement. Clin. Biochem. Rev. 13:55-59, 1992.
12. CARDOSO, G. C., C. POSADAS, O. O. Orvananos, et al Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). Chem. Physics Lipids 67/68:207-221, 1994.
13. CAZZALATO, G., G. PRAHASCH, S. GREEN, and G. M. KOSTNER. The determination of Lp(a) by rate end-point nephelometry. Clin. Chim. Acta 135:203-208, 1983.
14. COHEN, L. I. C. G. HARTFORD, and G. G. ROGERS. Lipoprotein(a) and cholesterol in body builders using anabolic androgenic steroids. Med. Sci. Sports Exerc. 28:176-179, 1996.
15. CORSETTI, J. P., J. A. STERRY, J. D. SPARKS. C. E. SPARKS, and M. WEINTRAUB. Effect of weight loss on serum lipoprotein(a) concentrations in an obese population. Clin. Chem. 37:1191-1195, 1991.
16. DAHLEN, G. H., J. R. GUYTON, M. ATTAR, J. A. FARMER, J. A. KAUTZ, and A. M. GOTTO. Association of levels of lipoprotein(a). plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74:758-765, 1986.
17. DAHLEN, G. H. Incidence of Lp(a) lipoprotein among populations. In Lipoprotein(a). A.M. Scanu (Ed.). San Diego: Academic Press, 1990. pp. 151-176.
18. DESMARIS, R., I. J. SAREMBOCK, C. R. AYERS, S. M. VERNON, E. R. POWERS, and L. W. GIMPLE. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasiy. Circulation 91:1403-1409. 1995.
19. DUELL, P. B., F. HAGEMENAS, and W. E. CONNOR. The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 17:1135-1140, 1994.
20. DUFAUN B., U. ORDER, H. GEYER, and W. HOLLMANN. C-reactive protein serum concentration in well-trained athletes. Int. J. Sports Med. 5:102-106, 1984.
21. DURSTINE, L. J. and W. L. HASKELL. Effects of exercise training on plasma lipids and lipoproteins. Ex. Sport Sci. Rev. 22:477-521, 1994.
22. FERGUSON. M. A., L. M. SZYMANSI, P. G. DAVIS, et al. Effect of a single session of exercise on lipoprotein(a) [Lp(a)]. Med. Sci. Sports Exerc. 27(Suppl.):S69. 1995.
23. FLESS, G. M., M. L. SNYDER, and A. M. SCANU. Enzyme-linked immunoassay for Lp(a). J. Lipid Res. 30:651-662, 1989.
24. GENEST, J. J. L. JENNER, J. R. MCNAMAKA. et al Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am. J. Cardiol. 67:1039-1045, 1991.
25. GUYTON, J. R., G. H. DAHLEN, W. PATSCH, J. A. KAUTZ, and A. GOTTO. Relationship of plasma lipoprotein(a) levels to race and apoprotein B. Arteriosclerosis 5:265-272, 1985.
26. HAENGGI, W. W. RIESEN, and M. H. BIRKHAEUSER. Postmenopausal hormone replacement therapy with tobolone decreases serum lipoprotein(a). Eur. J. Clin. Chem. Clin. Biochem. 31:645-650. 1993.
27. HAFFNER. S. M., K. K. GRUBER, P. A. Morales, et al Lipoprotein(a) concentration in Mexican Americans and non-Hispanic whites: the San Antonio heart study. Am. J. Epidemiol. 136:1060-1068, 1992.
28. HAFFNER, S. M. Lipoprotein(a) and diabetes: an update. Diabetes Care 16:819-823, 1993.
29. HASKELL, W. L. E. L. ALDERMAN, J. M. FAIR, cl al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. Circulation 89:975-990, 1994.
30. HELLER, F. R., J. JAMART, P. HONORE, et al. Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care 16:819-823, 1993.
31. HELLSTEN, G., K. BOMAN, G. HALLMANS, and G. DAHLEN. Lipids and endurance physical activity. Atherosclerosis 75:93-94, 1989.
32. HERMANN, W., J. BIERMANN, H. G. LINDHOFER, and G. KOSTNER. Modification of the atherogenic risk factor Lp(a) by supplementary fish oil administration in patients with moderate physical training. Med. Klin. 84:429-433, 1989.
33. HOFF, H. F. G. J. BECK, M. S. Skibinski, et al Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 77:1238-1244, 1988.
34. HOWARD, B. V., N.-A. LE, J. D. BELCHER, et al. Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann. Epidemiol. 4:341-350, 1994.
35. HUBINGER, L. M., L. T. MACKINNON, and F. LEPRE. Lipoprotein(a) [Lp(a)] levels in middle-aged male runners and sedentary controls. Med. Sci. Sports Exerc. 27:490-496, 1995.
36. HUBINGER, L. M. and L. T. MACKINNON. The effect of endurance training on lipoprotein(a) [Lp(a)] levels in middle-aged males. Med. Sci. Sports Exerc. 28:757-764, 1996.
37. HUBINGER, L. M., L. T. MACKINNON, L. BARBER, J. MCCOSKER, A. HOWARD, and F. LEPRE. The acute effects of treadmill running on lipoprotein(a) levels in males and females. Med. Sci. Sports Exerc. 29:436-442, 1997.
38. HUNNINGHAKE, D. B., E. A. STEIN, and M. J. MELLIES. Effects of one year treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein(a). J. Clin. Pharmacol. 33:574-580, 1993.
39. IRISH, A. B., L. A. SIMONS, and J. SIMONS. Lipoprotein(a) concentration in diabetes; relationship to proteinuria and diabetes control. Aust. N. Z. J. Med. 22:329-333, 1992.
40. ISRAEL, R. G., M. J. SULLIVAN, R. H. L. MARKS, R. S. CAYTON, and T. C. CHENIER. Relationship between cardiorespiratory fitness and lipoprotein(a) in men and women. Med. Sci. Sports Exerc. 26: 425-431, 1994.
41. JENNER, J. L. J. M. ORDOVAS, S. Lamon-Fava, et al Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: The Framingham offspring study. Circulation 87:1135-1141, 1993.
42. KLAUSEN, I. C., L. U. GERDES, H. MEINERTZ, F. A. HANSEN, and O. FAERMAN. Apoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with faimilial hypercholeterolemia treated with bile acid sequestration. Eur. J. Clin. Invest. 23:240-245, 1993.
43. LAMON-FAVA, S. D. JIMENEZ, J. C. CHRISTIAN, et al. The NHLBI twin study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 91:97-106, 1991.
44. LAWN. R. M., J. E. TOMLINSON, J. W. MCLEAN, and D. L. EATON. Molecular biology of apolipoprotein(a). In Lipoprotein(a). A.M. Scanu (Ed.). San Diego: Academic Press, 1990. pp. 25-40.
45. LICHTENSTEIN, A. H., L. M. AUSMAN, W. CARRASCO, et al. Effects of canola. corn. and olive oils on fasting and postprandial plasma lipoproteins in humans as pan of a national cholesterol education program step 2 diet. Arterioscler. Thromb. 13:1533-1542, 1993.
46. LIESEN, H., B. DUFAUX, and W. HOLLMANN. Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training. Eur. J. Appl. Physiol. Occup. Physiol. 37:243-254, 1977.
47. LOBO, R. A., M. NOTELOVITZ. L. BERNSTEIN, F. Y. KHAN, R. K. Ross, and W. L. PAUL. Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen. Am. J. Obstet. Gynecol. 166:1182-1190, 1992.
48. LOSCALZO. J. Lipoprotein(a) a unique risk factor for atherothrombotic disease. Arteriosclerosis 10:672-679, 1990.
49. MACAULEY, D., E. E. MCCRCM, G. STOTT, et al. Physical activity, lipids, apolipoproteins, and Lp(a) in the Northern Ireland health and activity survey. Med. Sci. Sports Exerc. 28:720-736, 1996.
50. MAEDA, S., A. ABE, M. SEISHIMA, K. MAKINO, A. NOMA, and M. KAWADE. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 78:145-150, 1989.
51. MANKOWITZ, K., R. SEIP, C. F. SEMENKOVICH, A. DAUGHERTY, and G. SCHONFELD. Short-term interruption of training affects both fasting and post-prandial lipoproteins. Atherosclerosis 95:181-189, 1992.
52. MCLEAN, J. W., J. E. TOMLINSON, W.-J. KUANG, et al cDNA sequence of human apolipoprotein(a) is homologous to plasminogcn. Nature 300:132-137, 1987.
53. RADER, D. J., W. A. MANN, W. CAIN, et al The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J. Clin. Invest. 95:1403-1408, 1995.
54. RANBY, M. Lp(a): strong hypervariable risk factor for atherosclerosis and cardiovascular disease. Clin. Hemostas. Rev. 5:9-10, 1991.
55. RHOADS, G. G., G. DAHLEN, K. BERG, N. E. MORTON, and A. L. DANNENBERG. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544, 1986.
56. SCANU, A. M. Update of lipoprotein(a). Curr. Opin. Upidol. 2: 253-258, 1991.
57. SCANU, A. M. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 267:3326-3329, 1992.
58. SCOTT, J. Thrombogenesis liked to atherogenesis at last? Nature 341:22-23, 1989.
59. SEIP, R. L. P. MOULIN, T. COCKE, et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler. Thromb. 13:1359-1367, 1993.
60. SORRENTINO, M. J. C. VlELHAUER, J. D. EISENBART, et al. Plasma lipoprotein(a) concentration and coronary artery disease in black patients compared with white patients. Am. J. Med. 93:658-662, 1992.
61. SUTER, E. and M. R. HAWES. Relationship of physical activity, body fat, diet, and blood lipid profile in youths 10-15 yr. Med. Sci. Sports Exerc. 25:748-754, 1993.
62. TAIMELA, A., J. S. A. VUKARI, K. V. K. PORKKA, and G. H. DAHLEN, Lipoprotein(a) levels in children and young adults: the influence of physical activity: The cardiovascular risk in young Finns study. Acta Paediatr. 83:1258-1263, 1994.
63. TONSTAD, S. L. OSE, C. GORBITZ, O. DJOSELAND, J. M. BARD, and J. C. FRUCHART. Efficacy of sequential hormone replacement therapy in the treatment of hypercholestcrolaemia among postmenopausal women. J. Intern. Med. 238:39-47, 1995.
64. UTERMANN, G. The mysteries of lipoprotein(a). Science 246:904910, 1989.
65. ZECHNER, R., G. DOSOYE, M. O. SCHWEDITSCH, K. P. PFEIFFER, and G. M. KOSTNER. Fluctuation of plasma lipoprotein(a) concentrations during pregnancy and postpartum. Metabolism 35:33-336, 1986.